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ABSTRACT
Overall 30-day mortality among patients with
nosocomial bacterial infections was analysed
according to antibiotic susceptibility in an 800-
bed hospital. Survival analysis identiﬁed three
factors associated with an increased mortality
rate: (1) a longer interval between admission and
onset of infection; (2) bacterial resistance; and (3)
the severity of the initial illness in the intensive
care unit. The increased mortality rate associated
with antibiotic resistance was observed for all
bacterial species with the exception of Gram-
positive cocci, and remained signiﬁcant or near-
signiﬁcant regardless of the hospital ward.
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Few studies of the consequences of nosocomial
infections (NIs) caused by antibiotic-resistant
bacteria have estimated the resulting excess mor-
tality. This lack of information may undermine
the efforts of hospital administrators to target
antibiotic resistance. The present study used
routine microbiological and administrative
databases to analyse the overall mortality rate
associated with NIs caused by antibiotic-resistant
bacteria in an 800-bed hospital in France.
The microbiology department database was
used to identify all bacterial infections documen-
ted in hospitalised patients during 1998. Systemic
NIs were deﬁned as the ﬁrst systemic infection in
a patient after hospital admission, with an inter-
val between admission and the date of the ﬁrst
positive culture of at least 3 days. Septicaemia
was deﬁned on the basis of at least one positive
blood culture, except coagulase-negative staphy-
lococci, for which two positive blood cultures
were required. Other infections were deﬁned,
independently of blood culture, as follows: acute
pneumonia on the basis of a positive protected
brush sample or bronchoalveolar lavage yielding
> 104 CFU ⁄mL; pleural infection on the basis of a
positive pleural effusion puncture; and abdom-
inal sepsis on the basis of a positive peritoneal
puncture. Lower urinary tract infections without
bacteraemia were excluded. The microbiology
database was then linked with the hospital’s
administrative database (patient age and sex, date
of admission, vital status at 30 days after the onset
of infection). No information was available
regarding any antibiotic treatment received by
the patient before or after the infectious episode,
or on non-vital outcome. Information needed to
calculate the mortality-predicting score at admis-
sion (MPM(cpr)) [1] was recorded for patients
hospitalised in the intensive care unit (ICU).
Bacteria were categorised as resistant, interme-
diately resistant or susceptible to antibiotics, as
recommended by the Antibiotic Susceptibility
Committee of the French Society of Microbiology
[2] and reported routinely to the responsible
clinician. Bacteria were grouped as: (1) Gram-
positive cocci; (2) Escherichia coli, Klebsiella spp.,
Enterobacter spp. and Serratia spp.; and (3) other
Gram-negative bacilli. Infections caused by other
bacteria were excluded. Methicillin-resistant sta-
phylococci, penicillin G-resistant streptococci,
ampicillin-resistant enterococci (no vancomycin-
resistant isolates were obtained), cefotaxime-
resistant Enterobacteriaceae, Pseudomonas spp.
resistant to ceftazidime or imipenem (all isolates
resistant to ﬂuoroquinolone were also resistant to
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these drugs) and Acinetobacter spp. resistant to
imipenem were classiﬁed as resistant.
Cases involving antibiotic-resistant bacteria
were compared to those involving intermediately
resistant or susceptible isolates. Univariate analy-
sis was ﬁrst used to identify predictors of 30-day
mortality, using Pearson’s Chi-square or Fisher’s
exact test for categorical variables, as appropriate,
and Student’s t-test or the Mann–Whitney U-test
for continuous variables. Continuous variables
were then dichotomised around the median for
univariate analysis of the survival probability in
the Kaplan–Meier method with the log-rank test.
The multivariate Cox proportional-hazards model
of survival was initially constructed with varia-
bles with a univariate log-rank p value of < 0.1,
followed by backward stepwise regression and
the maximum-likelihood method. A subgroup
analysis of patients hospitalised in the ICU took
into account the MPM(cpr) score [1].
In total, 115 patients were included, of whom 13
were lost to follow-up. Thus, 102 NIs were
analysed, comprising bacteraemia (86%), perito-
nitis (7%), pneumonia (5.5%) and pleuritis (1.5%).
Age, sex, hospital ward, and the interval between
admission and the onset of infection were not
associated with antibiotic resistance. The overall
30-day mortality rate was 18.6%, and was not
inﬂuenced by age (mean ± SD = 54.6 ± 16.8), sex
(66.7% males), the type of infection, the bacterial
species or the hospital ward. The mortality rate
was 34.2% for NIs caused by antibiotic-resistant
bacteria, compared with 9.4% for NIs caused by
susceptible isolates (p 0.002). Two factors were
associated independently with mortality, namely
the interval between admission and infection
onset (median 19 days), and infection by antibi-
otic-resistant bacteria (Table 1). The association
between the mortality rate and antibiotic-resistant
bacteria was independent of the hospital ward
(except in the case of Gram-positive cocci) (Fig. 1).
The 29 NIs identiﬁed in ICU patients did not
differ from those in non-ICU patients in terms of
age, sex, the bacterial species or antibiotic resist-
ance status. The strength of the association in this
subgroup between 30-day mortality and antibi-
otic-resistant bacteria persisted (hazards ra-
tio = 3.7; 95% CI, 0.7–18.9), with a hazard ratio
of 4.8 (95% CI, 0.7–18.9) observed with the
MPM(cpr) score dichotomised according to the
median, despite the lack of statistical signiﬁcance.
Overall, these results indicated a signiﬁcant
association between antibiotic-resistant bacteria
and the 30-day mortality rate in patients with
systemic nosocomial infections. This association
was observed regardless of the bacterial species
involved (except in the case of Gram-positive
cocci), and remained signiﬁcant or near-signiﬁ-
cant regardless of the ward specialty. Only four
methicillin-resistant Staphylococcus aureus strains
were isolated, which may explain the lack of any
apparent association between mortality and anti-
biotic resistance among Gram-positive cocci. As
found in other studies [3,4], the length of hospital
stay before NI onset was predictive of antibiotic
resistance and mortality. Age was not a risk factor
for mortality, possibly because of the limited age
range of the patients.
Among ICU patients, the more severe initial
illness did not modify the strength of the rela-
tionship between antibiotic-resistant bacteria and
mortality. Rather than the acute physiology and
chronic health evaluation (APACHE) score or the
simpliﬁed acute physiology (SAP) score, the
Table 1. Univariate and multivari-
ate analyses (Cox model) of factors
associated with mortality at 30 days
in patients with nosocomial infec-
tions (n = 102)
Factor
Unadjusted
hazards ratio
(95% CI) p value
Adjusted
hazards ratioa
(95% CI) p value
Male sex of patient 2.0 (0.7–6.1) 0.2 – –
Median age of patients 1.2 (0.5–3.0) 0.7 – –
Antibiotic-resistant bacteria 4.2 (1.6–11.1) 0.004 3.4 (1.3–8.9) 0.02
Median interval between admission
and infection onset
3.4 (1.2–9.4) 0.02 2.8 (1.0–7.8) 0.05
Bacterial species
Gram-positive cocci 1 – – –
Escherichia coli, Klebsiella spp.,
Enterobacter spp., Serratia spp.
0.9 (0.3–2.7) 0.7 – –
Other Gram-negative bacilli 1.4 (0.4–4.5) 0.6 – –
Department specialty
Medicine 1 – – –
Surgery 1.0 (0.3–3.3) 0.9 – –
Intensive care unit 1.8 (0.6–5.4) 0.3 – –
aThe terms of interaction were not statistically signiﬁcant (p > 0.1) and did not contribute signiﬁcantly to improving
the likelihood of the model.
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present study used the MPM(cpr) score because of
the ease of recording reliable information in a
retrospective cohort design, the strong validation
of this score’s ability to predict death among ICU
patients [1], and validation of the score’s ability to
predict death among ICU patients in the hospital
(data not shown).
However, this study has several potential limi-
tations. First, automated databases were used,
thereby hindering access to information on disease
severity, co-morbidity and ⁄ or underlyingdiseases,
and making it impossible to calculate severity
scores for patientswhowere not hospitalised in the
ICU. Furthermore, no attempt was made to review
the patients’ charts in order to determine whether
death was directly caused by the infection. Second,
it was not possible to analyse the reasons for the
observed difference in the mortality rate according
to antibiotic susceptibility. Nevertheless, this data-
linkage approach could rapidly provide hospital
decision-makers with pertinent information on the
clinical consequences of nosocomial infections
caused by antibiotic-resistant bacteria.
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% Fig. 1. Survival curves shown as a
function of the type of bacterium
(left) or the ward specialty (right) for
patients with nosocomial infections
caused by antibiotic-susceptible
(solid line) and antibiotic-resistant
(dashed line) bacteria. Circles, time
of death; arrows, ﬁnal time at which
patient information was available.
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